To accelerate revenue, WearOptimo launched its micro-wearable platform in the unregulated hydration market (for athletes and surgery) before pursuing its original, more complex goal of regulated heart attack detection. This de-risks the business and provides a faster path to sales.
WearOptimo solved the high cost and low volume of traditional silicon-based microneedle manufacturing by adapting nano-imprint lithography, a technique from the flat-screen TV industry. This "field hopping" innovation enabled them to produce millions of sensors for cents each.
Treat investor meetings like intimate tutorials, not one-way presentations. Ask questions to understand their knowledge base and worldview first, then guide them forward from that point. This builds a human connection and is more effective than a generic script.
WearOptimo's founder credits his team's disproportionate progress to in-person collaboration. By fostering "collision events"—spontaneous human interactions and whiteboard sessions—the company cultivates a high-performing culture similar to an elite sports team, which cannot be replicated virtually.
Admitting when you don't have an answer, especially during fundraising, is a powerful tool. It builds trust and credibility with potential investors. This honesty can also help identify gaps in your team or strategy that an investor might be able to help fill.
For a technical product to succeed, world-class science must be integrated with a high-level business strategy from day one. A founder can't simply build a great technology and expect it to succeed; every facet of the business, from marketing to sales, must be equally high-performing.
WearOptimo's sensor produces high-fidelity signals that would have been uninterpretable a decade ago. The product's viability hinges on a modern AI/ML team that can analyze these signals to create a "digital biomarker." The hardware is the portal, but the AI is the interpreter that creates value.